153 related articles for article (PubMed ID: 22349717)
1. Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.
Kitajima K; Kita M; Suzuki K; Senda M; Nakamoto Y; Sugimura K
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):840-5. PubMed ID: 22349717
[TBL] [Abstract][Full Text] [Related]
2. Preoperative PET/CT standardized FDG uptake values of pelvic lymph nodes as a significant prognostic factor in patients with endometrial cancer.
Chung HH; Cheon GJ; Kim HS; Kim JW; Park NH; Song YS
Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1793-9. PubMed ID: 24777491
[TBL] [Abstract][Full Text] [Related]
3. Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.
Kitajima K; Suenaga Y; Ueno Y; Maeda T; Ebina Y; Yamada H; Okunaga T; Kubo K; Sofue K; Kanda T; Tamaki Y; Sugimura K
Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1268-75. PubMed ID: 25833351
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
Song BI; Lee SW; Jeong SY; Chae YS; Lee WK; Ahn BC; Lee J
J Nucl Med; 2012 Sep; 53(9):1337-44. PubMed ID: 22870824
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR
J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.
Chung HH; Lee I; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ
Gynecol Oncol; 2013 Sep; 130(3):446-51. PubMed ID: 23791826
[TBL] [Abstract][Full Text] [Related]
8. The preoperative maximum standardized uptake value measured by 18F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients.
Walentowicz-Sadlecka M; Malkowski B; Walentowicz P; Sadlecki P; Marszalek A; Pietrzak T; Grabiec M
Biomed Res Int; 2014; 2014():234813. PubMed ID: 24719847
[TBL] [Abstract][Full Text] [Related]
9. Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer.
Chung HH; Nam BH; Kim JW; Kang KW; Park NH; Song YS; Chung JK; Kang SB
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1467-73. PubMed ID: 20352210
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma.
Chung HH; Cheon GJ; Kim JW; Park NH; Song YS
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):47-55. PubMed ID: 28828510
[TBL] [Abstract][Full Text] [Related]
12. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
Shim SH; Kim DY; Lee DY; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772
[TBL] [Abstract][Full Text] [Related]
13. SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients.
Antonsen SL; Loft A; Fisker R; Nielsen AL; Andersen ES; Høgdall E; Tabor A; Jochumsen K; Fagö-Olsen CL; Asmussen J; Berthelsen AK; Christensen IJ; Høgdall C
Gynecol Oncol; 2013 May; 129(2):298-303. PubMed ID: 23376805
[TBL] [Abstract][Full Text] [Related]
14. Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.
Lee HJ; Ahn BC; Hong CM; Song BI; Kim HW; Kang S; Jeong SY; Lee SW; Lee J
Nuklearmedizin; 2011; 50(5):204-13. PubMed ID: 21727990
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
17. The relationship between tumor mean standard uptake value (SUVmax) in preoperative PET/computed tomography and prognostic risk groups in endometrial cancer.
Bese T; Bicer E; Tetikli Kosuk A; Akovali B; Turan H; Kabasakal L; Demirkiran F
Nucl Med Commun; 2023 Mar; 44(3):204-211. PubMed ID: 36729416
[TBL] [Abstract][Full Text] [Related]
18. Lymph node standardized uptake values at pre-treatment
Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
[TBL] [Abstract][Full Text] [Related]
19. The preoperative SUVmax is superior to ADCmin of the primary tumour as a predictor of disease recurrence and survival in patients with endometrial cancer.
Nakamura K; Joja I; Fukushima C; Haruma T; Hayashi C; Kusumoto T; Seki N; Hongo A; Hiramatsu Y
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):52-60. PubMed ID: 22968401
[TBL] [Abstract][Full Text] [Related]
20. Post-treatment [¹⁸F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma.
Chung HH; Kim JW; Kang KW; Park NH; Song YS; Chung JK; Kang SB
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):74-80. PubMed ID: 20838994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
